Результаты поиска

Маккулярные внутренние слои сетчатки в множестве склерозов.

AIM: Оценить структурные изменения отдельных внутренних слоев сетчатки в макулярной области и определить наиболее затронутый слой в подгруппах пациентов с множественным склерозом (MS) по сравнению со здоровым контролем (HC). МЕТОДЫ: В целом ретроспективно были экспортированы данные о оптической согласованности томографии (OCT) от 507 пациентов с НР и 183 HC. Пациенты MS были сгруппированы по подтипам MS, первичным прогрессивным (PP), релапсирующим-излучающим (RR) и вторичным прогрессивным (SP). Толщина четырех внутренних слоев сетчатки, макульского слоя нервно-паралитического волокна (NFL), га

The Production Processes and Biological Effects of Intravenous Immunoglobulin.

Immunoglobulin is a highly diverse autologous molecule able to influence immunity in different physiological and diseased situations. Its effect may be visible both in terms of development and function of B and T lymphocytes. Polyclonal immunoglobulin may be used as therapy in many diseases in different circumstances such as primary and secondary hypogammaglobulinemia, recurrent infections, polyneuropathies, cancer, after allogeneic transplantation in the presence of infections and/or GVHD. However, recent studies have broadened the possible uses of polyclonal immunoglobulin showing that it ca

Mass Spectrometry Approaches for Identification and Quantitation of Therapeutic Monoclonal Antibodies in the Clinical Laboratory.

Therapeutic monoclonal antibodies (MAbs) are an important class of drugs used to treat diseases ranging from autoimmune disorders to B cell lymphomas to other rare conditions thought to be untreatable in the past. Many advances have been made in the characterization of immunoglobulins as a result of pharmaceutical companies investing in technologies that allow them to better understand MAbs during the development phase. Mass spectrometry is one of the new advancements utilized extensively by pharma to analyze MAbs and is now beginning to be applied in the clinical laboratory setting. The rise

Взаимоотношения между Т-помощником 1 Воспаление биомаркеров и гематологический индекс реакции пациентов с множественным склерозом.

Множественный склероз - это хроническая, прогрессивная, нетрудоспособная болезнь, связанная с высоким уровнем инфицирования, свидетельствами хронического воспаления и высоким коэффициентом смертности. Ненормальные свойства сыворотки цитокины и изменения в активности провокационных клеток были связаны с повторным излучением множественных склерозов (MS-RR). Цель этого исследования состоит в том, чтобы ввести новые подстрекательские коэффициенты, полученные на основе гематологических и липидных индексов в качестве дискриминаторов Т-помощи (Th)-1/Th-2 - деятельность в ОР-МС. Методы, используемые п

Estimating Out-of-Pocket Savings From Medicare Site-Neutral Payments on Colon, Lung, Ovarian, and Prostate Cancer Patients.

Site-neutral payment reforms seek to align Medicare reimbursement rates for common outpatient services across care sites. Recent reports have assessed the composite impact of site-neutral payment policies on beneficiaries, federal savings, and the commercial market. This analysis builds on such work, focusing on the potential patient-level savings of site-neutral reform for high-utilizing Medicare beneficiaries facing common chronic cancers. We compiled the outpatient services of standard treatment regimens for a typical lung, ovarian, prostate, and colon cancer patient over their first year o

Nurse self-evaluation of assessment of chemotherapy-induced peripheral neuropathy in patients with cancer.

The focus of this study was to assess the feasibility and clinical implementation of a standardized assessment for chemotherapy-induced peripheral neuropathy (CIPN) by registered nurses in patients undergoing neurotoxic chemotherapy. A total of 24 registered nurses from 4 different institutions were enrolled into the study. A pre- and posttest design was used to assess changes in nurses' attitudes, knowledge, and perceived skill in CIPN assessment. Using selected data collection instruments, nurses performed standardized assessments during the course of chemotherapy treatments. Patient-reporte

Временная плазмоцитома костей: исключительная локализация плазматомы одиночных костей, подчеркивающая роль мультимодальной съемки и многодисциплинарного управления.

Одинокая плазмоцитома (SP), редкая форма неоплазмы плазменных клеток, характеризуется моноклонным распространением плазменных клеток в локальном повреждении костей или мягких тканей. Временная плазмоцитома - это редкое проявление этого состояния, которое часто сопровождается такими неспециальными симптомами, как потеря слуха, утенок и краниальный нервный дефицит. Диагноз часто является сложным, учитывая совпадение с другими патологиями, такими, как холеститома и параганлиома. Гистопатологический анализ обычно показывает наличие листов плазменных клеток, которые подтверждаются иммунохимией для

Radiosurgery to the Medial Thalamus for Chronic Pain: A Single Group Experience and Review of Literature.

Introduction Chronic pain presents a significant challenge in achieving effective treatment and can greatly reduce patients' quality of life. Many individuals can undergo multiple therapies with limited success. Stereotactic medial thalamotomy is a treatment option for certain types of chronic pain when other measures have failed. This study aims to assess the efficacy and safety of radiosurgical medial thalamotomy based on nearly a decade of experience in managing chronic intractable pain of both malignant and non-malignant origins. Methods This retrospective study included 56 patients who un

Анатомические и морфологические вариации, связанные с микрографированием в оливках in vitro с использованием клональных корнеплодов.

Микрографтация является мощным биотехнологическим инструментом для микропродукции фруктовых деревьев и может применяться для клонального распространения непристойных видов, искоренения вирусов, управления патогенами, раннего выявления совместимости с скионом/кротовым скотом и размножения. Однако в оливках этот метод по-прежнему недостаточно изучен, особенно в том, что касается пересадки на полностью клональные корнеплоды. В этом исследовании мы разработали протокол in vitro микрографирования (IVM), основанный исключительно на клонально распространяемом материале. Two Культиваторы: "Galega" и "

Advanced Diagnostic Techniques

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention in adolescent and young adult (AYA) cancer survivors: results from the SURVAYA study.

PurposeFor adolescent and young adult (AYA) cancer survivors with a good prognosis, having a healthy lifestyle prevents morbidity and mortality after treatment. The aim of this study was to investigate the prevalence of (un)healthy lifestyle behaviors and related determinants in AYA cancer survivors.MethodsA population-based, cross-sectional study was performed among long-term (5-20 years) AYA cancer survivors (18-39 years old at diagnosis) registered within the Netherlands Cancer Registry. Self-reported questionnaires data about health behaviors were used to calculate the 2018 World Cancer Re

Совпадение в полном тексте источника
… For these items, we transposed daily food consumption to grams and estimated by multiplying the portion size by the consumption frequency for each food item. …

Patient-reported symptom burden in routine oncology care: Examining racial and ethnic disparities.

BackgroundRacial and ethnic disparities are well-documented in cancer outcomes such as disease progression and survival, but less is known regarding potential disparities in symptom burden.AimsThe goal of this retrospective study was to examine differences in symptom burden by race and ethnicity in a large sample of cancer patients. We hypothesized that racial and ethnic minority patients would report greater symptom burden than non-Hispanic and White patients.Methods and resultsA total of 5798 cancer patients completed the Edmonton Symptom Assessment Scale-revised (ESAS-r-CSS) at least once a

Association between miR-182 rs76481776 Polymorphism and Antidepressant Treatment Response in Patients with Depression.

ObjectiveThe efficacy of antidepressants is influenced by a combination of genetic, individual, and environmental factors. This study aimed to investigate the association between the miR-182 rs76481776 polymorphism and the response to antidepressant treatment in major depressive disorder (MDD) patients, and its underlying molecular mechanisms.MethodsThis study enrolled 180 MDD patients and 180 healthy controls. The rs76481776 genotype was determined using TaqMan-based qPCR. The severity of depression and treatment response were assessed using the Hamilton Depression Rating Scale (HAMD). The ex

Deatary Inflammatory Score (DIS) и Life Score (LIS) «Влияние на многоразовый склероз» (LIS).

Фон/цели: Множественный склероз (MS) — иммунопосредованное демиелионирующее заболевание центральной нервной системы с изменяющимися уровнями воспаления и глиоза. Факторы питания и образа жизни могут влиять на развитие НР, а также способствовать воспалению. Целью нынешнего исследования является оценка взаимосвязи между пищевым и жизненным потенциалом и остротой множественных склерозов. Методы: Применялась схема перекрестного исследования. Сбор данных включал демографическую, неврологическую информацию и информацию о питании. На основе эталонного протокола были рассчитаны диетический воспламенит

Совпадение в полном тексте источника
… For most of the food included in the FFQ, a specific portion size was indicated (e.g., 100 g of fish). If the amount of food consumed was different from the reported portion, the size was adjusted. …

Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without dasatinib for glioblastoma.

BackgroundDasatinib is an oral inhibitor of the Src kinase family, with preclinical data indicating impact on gliomagenesis, tumor invasion, and radiosensitivity.MethodsNorth Central Cancer Treatment Group N0877 is a phase 1 dose escalation and phase II randomized study evaluating the maximum tolerated dose (MTD), safety, and efficacy of dasatinib with radiation and temozolomide (TMZ) for glioblastoma. Following identification of the MTD, adult patients with a histologic diagnosis of glioblastoma were randomized 2:1 between dasatinib given with standard concurrent and adjuvant TMZ, versus plac

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.

BackgroundThe binding of CXCR4 with its ligand (stromal-derived factor-1) maintains hematopoietic stem/progenitor cells (HSPCs) in a quiescent state. We hypothesized that blocking CXCR4/SDF-1 interaction after hematopoietic stem cell transplantation (HSCT) promotes hematopoiesis by inducing HSC proliferation.MethodsWe conducted a phase I/II trial of plerixafor on hematopoietic cell recovery following myeloablative allogeneic HSCT. Patients with hematologic malignancies receiving myeloablative conditioning were enrolled. Plerixafor 240 μg/kg was administered subcutaneously every other day begin

A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy.

Antibody-Drug Conjugates (ADCs) represent an innovative class of potent anti-cancer compounds that are widely used in the treatment of hematologic malignancies and solid tumors. Unlike conventional chemotherapeutic drug-based therapies, that are mainly associated with modest specificity and therapeutic benefit, the three key components that form an ADC (a monoclonal antibody bound to a cytotoxic drug via a chemical linker moiety) achieve remarkable improvement in terms of targeted killing of cancer cells and, while sparing healthy tissues, a reduction in systemic side effects caused by off-tum

Oral health status and quality of life in female patients receiving low dose bone-modifying agents for cancer treatment-induced bone loss: a single-center exploratory study.

INTRODUCTION: Breast cancer patients, undergoing low-dose bone-modifying agent (LD-BMA) therapy for cancer treatment-induced bone loss (CTIBL), represent an emerging category at risk of Medication-Related (MRONJ) low (<1%) but not absent. However, data on their oral health status and quality of life related are currently limited. This single-center exploratory study aimed to assess oral health conditions, periodontal status, and oral health-related quality of life in non-metastatic breast cancer patients under LD-BMA therapy for CTIBL. MATERIALS AND METHODS: Forty patients were consecutively

Preclinical evaluation of the novel, orally bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in spontaneous canine cancer: results of a phase I study.

BackgroundThe purpose of this study was to evaluate the activity of Selective Inhibitors of Nuclear Export (SINE) compounds that inhibit the function of the nuclear export protein Exportin 1 (XPO1/CRM1) against canine tumor cell lines and perform a Phase I clinical trial of KPT-335 in dogs with spontaneous cancer to provide a preliminary assessment of biologic activity and tolerability.Methods and findingsCanine tumor cell lines derived from non-Hodgkin lymphoma (NHL), mast cell tumor, melanoma and osteosarcoma exhibited growth inhibition and apoptosis in response to nanomolar concentrations o

Characteristics of post hoc subgroup analyses of oncology clinical trials: a systematic review.

BackgroundSubgroup analyses in clinical trials assess intervention effects on specific patient subgroups, ensuring generalizability. However, they are usually only able to generate hypotheses rather than definitive conclusions. This study examined the prevalence and characteristics of post hoc subgroup analysis in oncology.MethodsWe systematically reviewed published subgroup analyses from 2000 to 2022. We included articles presenting secondary, post hoc, or subgroup analyses of interventional clinical trials in oncology, cancer survivorship, or cancer screening, published separately from the o